Labeling & UDI
27 articles
EUDAMED Bulk Upload Validation Error Playbook: Diagnose and Fix XML/XSD Rejections Before the May 2026 Deadline
A systematic playbook for diagnosing and resolving EUDAMED bulk upload validation errors — covering XSD schema failures, Basic UDI-DI/UDI-DI mismatches, EMDN code issues, certificate linkage errors, DTX error codes, NB confirmation bottlenecks, and a pre-upload validation checklist.
Home-Use IVD Invalid-Result Workflow: How to Design, Document, and Monitor Invalid Results for Consumer Diagnostics
Operational guide to the invalid-result workflow for home-use and self-test IVDs — covering invalid rate targets, lay-user error coding, repeat-test instructions, IFU comprehension, customer support scripts, specimen collection errors, adverse event handling, and postmarket trending.
RUO-to-IVD Conversion Firewall: How to Convert a Research-Use Assay into an IVD Without Contaminating Your Evidence Base
Operational guide to converting an RUO-labeled assay or reagent into a cleared or approved IVD — covering marketing claims cleanup, distributor scripts, customer notices, historical data triage, validation bridge strategy, complaint transition, sales training, and evidence firewall construction.
Global UDI Compliance 2026: Complete Deadlines Guide by Country (EU, US, Switzerland, Australia, China, Brazil, Singapore)
2026 is the most consequential year for medical device UDI compliance globally. Mandatory deadlines hit in the EU (May 28), Switzerland (July 1), Australia (July 1), and China. This guide covers every active UDI system, class-by-class deadlines, data requirements, and what happens if you miss them.
Swissdamed Goes Mandatory July 2026: Complete Guide to Swiss Medical Device Registration and UDI Compliance
Switzerland's swissdamed database becomes mandatory on July 1, 2026, requiring all medical device manufacturers to register products and upload UDI data. This guide covers the Product Module, CH REP requirements, M2M functionality, grace period rules, immediate registration triggers, and the consequences of non-compliance.
Direct-to-Consumer Genetic Tests: FDA, FTC, Privacy, Clinical Validity, and Claims Control
Regulatory, commercial, and privacy risk guide for direct-to-consumer (DTC) genetic testing companies — covering FDA oversight of DTC IVDs, wellness vs. medical claims boundaries, analytical and clinical validity requirements, risk report authorization, GINA and state privacy laws, FTC advertising substantiation, 23andMe bankruptcy data precedent, and practical guidance on claims that change regulatory status.
EUDAMED Registration Mistakes: The 10 Most Common Errors and How to Fix Them Before May 28, 2026
With EUDAMED becoming mandatory on May 28, 2026, manufacturers are discovering that registration is far more complex than a simple data upload. Here are the 10 most common mistakes — and exactly how to avoid each one.
Home-Use and Self-Test IVDs: Regulatory Pathway, Human Factors, Labeling, and Post-Market Risk Controls
Practical regulatory guide for home-use and self-test in vitro diagnostic devices — covering FDA pathways (OTC, prescription home use, CLIA waiver), EU IVDR self-testing requirements, human factors and lay-user usability, specimen collection errors, labeling requirements, DTC vs provider-ordered models, and post-market surveillance for consumer diagnostics.
ISO 17664 Reprocessing Validation for Reusable Medical Devices: Standards, FDA Expectations, and Submission Evidence
Manufacturer-facing guide to reprocessing validation for reusable medical devices under ISO 17664-1, ISO 17664-2, FDA guidance, and EU MDR — covering cleaning, disinfection, sterilization validation, worst-case device families, IFU content, and premarket submission evidence.
Reprocessing Instructions in Medical Device IFUs: How to Write User-Friendly, Validated, Audit-Ready Instructions
Step-by-step guide to writing reprocessing instructions for reusable medical device IFUs — covering point-of-use treatment, cleaning, disinfection, sterilization, drying, storage, reuse life claims, warnings, usability validation, and audit readiness per FDA guidance, ISO 17664, and ISO 20417.
RUO vs IUO vs IVD Labeling: When Research-Use and Investigational-Use Products Become Regulated Diagnostics
Practical labeling and intended-use boundary guide for IVD manufacturers — covering FDA RUO/IUO guidance, clinical diagnostic use triggers, enforcement actions, marketing language risk, distributor behavior, and a decision tree for regulatory classification.
Colombia Medical Device Registration Cost 2026: INVIMA Representative Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
How much does it cost to register a medical device in Colombia in 2026? A buyer-side breakdown of Colombia Representative (Representante Legal) service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for Class I/IIa uncontrolled and Class IIb/III controlled pathways.
eIFU Electronic Instructions for Use for Medical Devices: EU MDR Regulation 2025/1234, FDA Rules, Website Access, QR Codes, and Paper IFU Requirements
Complete guide to electronic Instructions for Use (eIFU) for medical devices — EU Implementing Regulation 2021/2226 as amended by Regulation 2025/1234 expanding eIFU to all professional-use devices, risk assessment requirements, labeling obligations, EUDAMED UDI integration, FDA electronic IFU policy under 21 CFR Part 801, paper IFU fallback rules, IVDR provisions for IVDs, SaMD-specific guidance, validation expectations, and implementation checklist.
Mexico Medical Device Registration Cost 2026: MRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
Pure Global publishes Mexico MRH service at $2,000/year flat for Class I and $3,000/year for Class II/III — versus $15,000–$30,000 Year 1 under hourly billing. A buyer-side breakdown of Mexico Registration Holder (MRH) pricing models with 3-year cash flow scenarios, switching playbook, and RFP template for COFEPRIS submissions and the Equivalence Pathway.
Switzerland Swissmedic Medical Device Registration Guide (2026)
How to register and sell medical devices in Switzerland under Swissmedic — CH-REP requirements, MedDO/IvDO framework, swissdamed registration deadlines (July 2026), CE marking reliance, classification, fees, and post-market obligations after the EU MRA lapse.
Batch Records for Medical Devices: Complete Guide to BMR, EBR, and DHR — Paper vs Electronic, 21 CFR 210/211 Compliance, and FDA QMSR Requirements
Master batch manufacturing records (BMR), electronic batch records (EBR), and device history records (DHR) for medical device manufacturing. Covers 21 CFR 210/211, 21 CFR Part 820/QMSR, ISO 13485, paper vs electronic systems, review workflows, deviation management, and FDA inspection readiness.
FDA Emergency Use Authorization (EUA) for Medical Devices: Complete Regulatory Pathway Guide
Comprehensive guide to the FDA Emergency Use Authorization (EUA) pathway for medical devices under Section 564 of the FD&C Act — legal basis, CBRN emergency triggers, statutory criteria, submission process, EUA vs 510(k)/PMA comparison, post-COVID transition framework, and current active EUAs.
EU Declaration of Conformity (DoC) for Medical Devices: Complete Template Guide with 2026 Language and Digital Requirements
How to draft a fully compliant EU Declaration of Conformity under MDR Article 19 and Annex IV — content requirements, language obligations per Member State, legacy device considerations, digital DoC proposals for 2026, and a complete annotated template covering Class I through III devices.
FDA Medical Device Advertising and Promotion Compliance Guide (2026)
Complete guide to FDA medical device advertising and promotion regulations — 21 CFR Part 801 labeling requirements, OPEQ enforcement, off-label promotion rules, social media compliance, FTC oversight, warning letters, and practical strategies for compliant promotional claims.
ISO 15223-1 Medical Device Symbols: Complete Labeling and Marking Guide (2026)
A comprehensive guide to ISO 15223-1:2021 medical device labeling symbols — the 2025 Amendment 1 EU REP change, complete symbol reference by category, MDR/IVDR compliance requirements, symbol validation per ISO 15223-2, and practical implementation for manufacturers.